特发性肺纤维化患者肺功能变化与死亡风险
基于IPF前瞻性结局注册研究1001例患者,中位随访38.4个月,采用含时变协变量的Cox模型分析。结果显示FVC或Dlco占预计值百分比各阈值下降均与后续死亡或肺移植风险显著相关,即使小幅下降也提示预后。
要点
- FVC占预计值下降≥2%、≥5%、≥10%分别与后续死亡或肺移植风险增加1.8倍、2.3倍、2.7倍相关。
- Dlco占预计值下降≥2%、≥5%、≥10%、≥15%分别与风险增加2.0倍、1.4倍、1.5倍、1.9倍相关。
- Dlco相对下降较绝对下降的风险增加通常更大,FVC无此现象。
核心结论
- IPF患者FVC和Dlco占预计值百分比即使小幅下降也与后续死亡或肺移植风险显著相关,可提示预后。
研究设计与样本
- IPF前瞻性结局注册研究纳入1001例在入组中心6个月内诊断或确认的IPF患者,中位随访38.4个月。
- 采用含时变协变量的Cox比例风险模型评估肺功能下降阈值与后续死亡或肺移植风险的关联,模型未调整或调整FVC和Dlco占预计值百分比、年龄、性别、吸烟状态、BMI、抗纤维化治疗及入组时氧疗。
主要发现
- 未调整和调整分析中,FVC和Dlco占预计值百分比所有下降阈值均与死亡或肺移植风险显著相关。
- 调整分析中,FVC占预计值绝对下降≥2%、≥5%、≥10%分别与后续死亡或肺移植风险增加1.8倍、2.3倍、2.7倍相关。
- 调整分析中,Dlco占预计值绝对下降≥2%、≥5%、≥10%、≥15%分别与后续死亡或肺移植风险增加2.0倍、1.4倍、1.5倍、1.9倍相关。
- 对于Dlco而非FVC,基于相对下降阈值达到标准的患者风险增加通常大于基于绝对下降阈值者。
临床怎么用
- 临床随访IPF患者时应关注FVC和Dlco占预计值百分比的小幅下降,即使下降幅度较小也提示预后不良。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease associated with lung function decline and high mortality. RESEARCH QUESTION: What are the associations between thresholds of lung function decline and the risk of mortality in patients with IPF? STUDY DESIGN AND METHODS: The Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry enrolled patients with IPF that was diagnosed or confirmed at the enrolling center within the prior 6 months. Associations between time to first decline in FVC or diffusing capacity of the lungs for carbon monoxide (Dlco) of ≥ 2% predicted, ≥ 5% predicted, and ≥ 10% predicted (and ≥ 15% predicted for Dlco) and risk of subsequent death or lung transplantation was assessed using Cox proportional hazards models with a time-dependent covariate. Models were unadjusted or adjusted for FVC and Dlco % predicted, age, sex, smoking status, BMI, antifibrotic treatment (yes or no), and oxygen use at enrollment. RESULTS: Among 1,001 patients, median follow-up time was 38.4 months. Significant associations were observed between all thresholds of decline in FVC and Dlco % predicted and the risk of death or lung transplantation in unadjusted and adjusted analyses. In adjusted analyses, absolute declines in FVC of ≥ 2% predicted, ≥ 5% predicted, and ≥ 10% predicted were associated with 1.8-fold, 2.3-fold, and 2.7-fold increases in the risk of subsequent death or lung transplantation, whereas absolute declines in Dlco of ≥ 2% predicted, ≥ 5% predicted, ≥ 10% predicted, and ≥ 15% predicted were associated with 2.0-fold, 1.4-fold, 1.5-fold, and 1.9-fold increases in the risk of subsequent death or lung transplantation, respectively. For Dlco, but not FVC, the increase in risk generally was greater for patients meeting a threshold based on a relative rather than an absolute decline. INTERPRETATION: Our results show that even small declines in FVC and Dlco % predicted inform prognosis in patients with IPF. CLINICAL TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01915511; URL: www. CLINICALTRIALS: gov.
引用
- Oldham JM, Neely ML, Wojdyla DM, et al. Changes in Lung Function and Mortality Risk in Patients With Idiopathic Pulmonary Fibrosis. Chest. 2025. PMID: 40020995. doi:10.1016/j.chest.2025.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。